Parkview Nursing and Rehabilitation Revenue and Competitors
Employee Data
- Parkview Nursing and Rehabilitation has 31 Employees.
- Parkview Nursing and Rehabilitation grew their employee count by 182% last year.
Parkview Nursing and Rehabilitation's People
Name | Title | Email/Phone |
---|
Parkview Nursing and Rehabilitation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 31 | 182% | N/A | N/A |
What Is Parkview Nursing and Rehabilitation?
Parkview is a leading provider of nursing, rehabilitation, and independent living services in Wilmington, Delaware, offering the comforts of home with attentive, 24-hour nursing support. But we’re so much more than that. We’re a family. From our outstanding staff to the extra touches that make life at Parkview feel like home, ours is a community where warm, compassionate people give their all to those in their care.That mission can’t be built on capabilities and amenities alone. It’s built on people. People who see other people, not patients. People who love what they do, almost as much as who they do it for.\n\nOur staff is far more than the sum of its degrees, certifications, and experience. The Parkview team is driven by a genuine love of people. It’s this compassion that compels us to welcome every resident as family. To us, that’s exactly what they are.From helping seniors get back on their feet after a bad fall, to supporting Alzheimer’s patients in their quest for safe, meaningful independent living, to bringing them round-the-clock comfort and care as they cope with chronic health issues. Whatever your loved one needs, you’ll find it at Parkview.
keywords:N/AN/A
Total Funding
31
Number of Employees
N/A
Revenue (est)
182%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 31 | -6% | N/A |
#2 | N/A | 31 | 244% | N/A |
#3 | $3.6M | 31 | 48% | N/A |
#4 | N/A | 31 | 24% | N/A |
#5 | N/A | 31 | 48% | N/A |